Authors:
CONINX R
PFYFFER GE
MATHIEU C
SAVINA D
DEBACKER M
JAFAROV F
JABRAILOV I
ISMAILOV A
MIRZOEV F
DEHALLER R
PORTAELS F
Citation: R. Coninx et al., DRUG-RESISTANT TUBERCULOSIS IN PRISONS IN AZERBAIJAN - CASE-STUDY, BMJ. British medical journal, 316(7142), 1998, pp. 1423-1425
Authors:
DEBACKER M
DEVROEY C
LESAFFRE E
SCHEYS I
DEKEYSER P
Citation: M. Debacker et al., 12 WEEKS OF CONTINUOUS ORAL-THERAPY FOR TOENAIL ONYCHOMYCOSIS CAUSED BY DERMATOPHYTES - A DOUBLE-BLIND COMPARATIVE TRIAL OF TERBINAFINE 250MG DAY VERSUS ITRACONAZOLE 200 MG/DAY/, Journal of the American Academy of Dermatology, 38(5), 1998, pp. 57-63
Authors:
WALLEMACQ PE
REDING R
SOKAL EM
DEGOYET JD
DECLETY SC
VANLEEUW V
DEBACKER M
OTTE JB
Citation: Pe. Wallemacq et al., CLINICAL PHARMACOKINETICS OF NEORAL IN PEDIATRIC RECIPIENTS OF PRIMARY LIVER-TRANSPLANTS, Transplant international, 10(6), 1997, pp. 466-470
Authors:
MALAISE MG
DEKEYSER P
DEBACKER M
VANLIERDE MA
LESAFFRE E
Citation: Mg. Malaise et al., THE USE OF SANDIMMUN(R) (CYCLOSPORINE-A) IN SEVERE REFRACTORY RHEUMATOID-ARTHRITIS - THE BELGIAN EXPERIENCE, Clinical rheumatology, 14, 1995, pp. 26-32
Authors:
DEKEYSER P
DEBACKER M
MASSART DL
WESTELINCK KJ
Citation: P. Dekeyser et al., 2-WEEK ORAL TREATMENT OF TINEA-PEDIS, COMPARING TERBINAFINE (250 MG DAY) WITH ITRACONAZOLE (100 MG/DAY) - A DOUBLE-BLIND, MULTICENTER STUDY/, British journal of dermatology, 130, 1994, pp. 22-25